0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

Amgen Calls 2026 a “Springboard Year” as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event [Yahoo! Finance]

Amgen Inc. (AMGN)  More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Morgan-hosted event that the company views 2026 as a “springboard year,” driven in part by what he described as a significant amount of clinical data expected across the portfolio. Bradway also reviewed 2025 performance and outlined several product and pipeline priorities heading into the new year. Bradway said the company delivered on the objectives it outlined a year earlier, citing financial growth, multiple regulatory approvals, pipeline progression, and balance sheet actions. Revenue and earnings: Through the first nine months of 2025, Amgen reported 10% revenue growth and 14% earnings per share growth, paced by what Bradway called its 14 blockbuster products. Regulatory approvals: Bradway said the company received five FDA approvals in 2025. MariTide development: Amgen initiated six Phase 3 programs for MariTide during 2025. Repatha clinical data: Bradway highlighted Vesalius trial results presented in 2025, including a 36% reduction in first heart attack risk among pe [Read more]
IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
AMGN
NEWS
AMGN
Earnings
AMGN
Analyst Actions
AMGN
SEC Filings
Stockreport

Amgen Calls 2026 a “Springboard Year” as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event [Yahoo! Finance]

Amgen Inc.  (AMGN) 
More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Morgan-hosted event that the company views 2026 as a “springboard year,” driven in part by what he described as a significant amount of clinical data expected across the portfolio. Bradway also reviewed 2025 performance and outlined several product and pipeline priorities heading into the new year. Bradway said the company delivered on the objectives it outlined a year earlier, citing financial growth, multiple regulatory approvals, pipeline progression, and balance sheet actions. Revenue and earnings: Through the first nine months of 2025, Amgen reported 10% revenue growth and 14% earnings per share growth, paced by what Bradway called its 14 blockbuster products. Regulatory approvals: Bradway said the company received five FDA approvals in 2025. MariTide development: Amgen initiated six Phase 3 programs for MariTide during 2025. Repatha clinical data: Bradway highlighted Vesalius trial results presented in 2025, including a 36% reduction in first heart attack risk among pe [Read more]
IMPACT SNAPSHOT
EVENT TIME:
AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS